Rockefeller Capital Management L.P. Sells 11,995 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Rockefeller Capital Management L.P. cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 28.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 30,328 shares of the company’s stock after selling 11,995 shares during the period. Rockefeller Capital Management L.P.’s holdings in HealthEquity were worth $2,440,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Envestnet Asset Management Inc. boosted its stake in shares of HealthEquity by 39.4% during the 1st quarter. Envestnet Asset Management Inc. now owns 29,485 shares of the company’s stock worth $2,005,000 after purchasing an additional 8,328 shares during the period. M&T Bank Corp boosted its stake in shares of HealthEquity by 0.7% during the 1st quarter. M&T Bank Corp now owns 43,333 shares of the company’s stock worth $2,945,000 after purchasing an additional 320 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in shares of HealthEquity by 23.1% during the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 3,295 shares of the company’s stock worth $224,000 after purchasing an additional 619 shares during the period. Alliancebernstein L.P. boosted its stake in shares of HealthEquity by 3.6% during the 1st quarter. Alliancebernstein L.P. now owns 201,161 shares of the company’s stock worth $13,679,000 after purchasing an additional 7,003 shares during the period. Finally, Rhumbline Advisers boosted its stake in shares of HealthEquity by 4.0% during the 1st quarter. Rhumbline Advisers now owns 231,359 shares of the company’s stock worth $15,732,000 after purchasing an additional 8,864 shares during the period.

Shares of HQY opened at $64.06 on Friday. The company has a 50 day moving average price of $68.92 and a 200-day moving average price of $73.49. HealthEquity, Inc. has a fifty-two week low of $45.82 and a fifty-two week high of $93.32. The stock has a market capitalization of $5.35 billion, a PE ratio of 6,406.00, a PEG ratio of 5.22 and a beta of 1.37. The company has a debt-to-equity ratio of 0.48, a quick ratio of 4.50 and a current ratio of 4.65.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 7th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. HealthEquity had a net margin of 0.10% and a return on equity of 5.25%. The firm had revenue of $189.10 million during the quarter, compared to analysts’ expectations of $184.99 million. During the same quarter in the prior year, the company earned $0.29 EPS. The company’s revenue was up 7.4% compared to the same quarter last year. Equities research analysts forecast that HealthEquity, Inc. will post 0.95 EPS for the current year.

In related news, insider Darcy G. Mott sold 6,000 shares of the business’s stock in a transaction that occurred on Monday, June 21st. The shares were sold at an average price of $77.18, for a total transaction of $463,080.00. Following the completion of the transaction, the insider now owns 85,052 shares in the company, valued at approximately $6,564,313.36. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Edward Bloomberg sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, July 26th. The stock was sold at an average price of $75.00, for a total transaction of $75,000.00. Following the transaction, the chief operating officer now owns 39,195 shares of the company’s stock, valued at approximately $2,939,625. The disclosure for this sale can be found here. Insiders sold a total of 41,635 shares of company stock valued at $3,121,958 in the last ninety days. Corporate insiders own 2.80% of the company’s stock.

A number of research firms recently commented on HQY. Cantor Fitzgerald lifted their price target on shares of HealthEquity from $82.00 to $85.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 8th. Raymond James boosted their price objective on shares of HealthEquity from $85.00 to $90.00 and gave the company a “strong-buy” rating in a research report on Thursday, June 10th. SVB Leerink raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and set a $80.00 price objective for the company in a research report on Thursday, September 9th. BTIG Research reissued a “hold” rating on shares of HealthEquity in a research report on Tuesday, June 8th. Finally, Stephens assumed coverage on shares of HealthEquity in a research report on Thursday, July 1st. They issued an “overweight” rating and a $100.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, HealthEquity has an average rating of “Buy” and a consensus target price of $87.40.

HealthEquity Profile

HealthEquity, Inc provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives.

Read More: The risks of owning bonds

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.